Cargando…
Association between Maternal Thyroxine and Risk of Fetal Congenital Heart Defects: A Hospital-Based Cohort Study
BACKGROUND: Evidence for the association between maternal thyroxine concentration and the risk of fetal congenital heart defects (CHDs) is absent. We aimed to study the association of maternal free and total thyroxine (FT4 and TT4) concentrations and the free-to-total thyroxine proportion (FTT4P, %)...
Autores principales: | Dong, Jing, Peng, Ting, Li, Ming-Qing, Xie, Feng, Wu, Jiang-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933103/ https://www.ncbi.nlm.nih.gov/pubmed/35311035 http://dx.doi.org/10.1155/2022/3859388 |
Ejemplares similares
-
Preeclampsia and Fetal Congenital Heart Defects
por: Ferreira, Bárbara D., et al.
Publicado: (2022) -
Utility of Fetal Echocardiography with Acute Maternal Hyperoxygenation Testing in Assessment of Complex Congenital Heart Defects
por: Patel, Sheetal R., et al.
Publicado: (2023) -
Intra-amniotic thyroxine to treat fetal goiter
por: Kim, Min-Jung, et al.
Publicado: (2016) -
Maternal traditional Chinese medicine exposure and risk of congenital malformations: a multicenter prospective cohort study
por: Peng, Ting, et al.
Publicado: (2023) -
Complex Congenital Heart Diseases and Pregnancy: Maternal and Fetal Risks
por: Moreira, Valéria de Melo
Publicado: (2019)